Literature DB >> 8439001

Mechanism of increased susceptibility to infection following hemorrhage.

I H Chaudry1, A Ayala.   

Abstract

Although hemorrhage is known to cause increased susceptibility to infection, the precise mechanism remains unknown. Regional hypoxia due to reduced blood flow following hemorrhage appears to be a primary mediator that initiates the cascade of events leading to immunodepression and increased susceptibility to infection. This was evident from depression of lymphocyte functions, production of various lymphokines, macrophage expression of receptors involved in opsonin-mediated phagocytosis, and antigen presentation function of peritoneal, splenic, and Kupffer cells following hemorrhage. The depression in various immune functions is apparent immediately after hemorrhage and persists for a prolonged period of time, despite volume resuscitation. Furthermore, it appears that the increased release of systemic mediators, such as interleukin-1 (IL-1), IL-6, tumor necrosis factor, transforming growth factor type beta, and prostaglandin E2 is associated with marked depression in immune responses and increased susceptibility to infection following hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439001     DOI: 10.1016/s0002-9610(05)81208-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Progress in burns research: a review of advances in burn pathophysiology.

Authors:  P I Jewo; I O Fadeyibi
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

3.  Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin.

Authors:  A Ayala; C S Chung; Y X Xu; T A Evans; K M Redmond; I H Chaudry
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans.

Authors:  Rami A Namas; Yoram Vodovotz; Khalid Almahmoud; Othman Abdul-Malak; Akram Zaaqoq; Rajaie Namas; Qi Mi; Derek Barclay; Brian Zuckerbraun; Andrew B Peitzman; Jason Sperry; Timothy R Billiar
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

5.  Opiates and the development of post-injury complications: a review.

Authors:  Martin G Schwacha
Journal:  Int J Clin Exp Med       Date:  2008-01-20

6.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

7.  Systemic cytokine response after emergency and elective surgery for colorectal carcinoma.

Authors:  Fausto Catena; Luca Ansaloni; Andrea Avanzolini; Salomone Di Saverio; Luigi D'Alessandro; Mario Maldini Casadei; Antonio Pinna
Journal:  Int J Colorectal Dis       Date:  2009-03-13       Impact factor: 2.571

8.  Inducible nitric oxide synthase contributes to immune dysfunction following trauma.

Authors:  Sophie S Darwiche; Roman Pfeifer; Christoph Menzel; Xiangcai Ruan; Marcus Hoffman; Changchun Cai; R Savanh Chanthaphavong; Patricia Loughran; Bruce R Pitt; Rosemary Hoffman; Hans-Christoph Pape; Timothy R Billiar
Journal:  Shock       Date:  2012-11       Impact factor: 3.454

Review 9.  Year in review 2008: Critical Care--trauma.

Authors:  Jeffery C Metzger; Alexander L Eastman; Paul E Pepe
Journal:  Crit Care       Date:  2009-10-21       Impact factor: 9.097

10.  Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.

Authors:  Y M Yao; S Bahrami; G Leichtfried; H Redl; G Schlag
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.